News and Press

Press releases

Renowned horse race jockey and trainer conducts pilot test of LAMPlify®

Regulatory

Diagonal Bio AB (publ) (“Diagonal Bio” or “the Company”) announces that one of Sweden’s most accomplished horse race trainers, Madeleine Smith, has initiated a six-month pilot test of LAMPlify®.  The pilot test will focus on enhancing equine health and performance through early detection of potential respiratory viruses in horses. The test will be conducted via Madeleine Smith’s horse race training operation M. Smith Galopp.

Read more

Diagonal Bio announces pilot test with LAMPlify® at Kolgjini Stables

Regulatory

Diagonal Bio AB (publ) (“Diagonal Bio” or “the Company”) announces a partnership with Kolgjini Stables (Stall Kolgjini), founded by renowned harness racer Lutfi Kolgjini, to conduct a three-month pilot test. Kolgjini Stables is a Swedish stable known for its expertise in growing horses for both breeding and for top-tier national and international competition. This pilot test starts immediately and aims to evaluate the potential of the LAMPlify® platform to provide rapid and accurate virus detection in horses.

Read more

Diagonal Bio announces that it is exploring financing options

Regulatory

Diagonal Bio AB (“Diagonal Bio” or “the Company”) today announces that the Board of Directors of the Company has engaged financial and legal advisors and decided to explore potential financing alternatives to secure the Company’s ongoing operations and support its strategic goals. The current funds last until mid-February 2025.

Read more

Diagonal announces first pilot test at a stud with LAMPlify®

Regulatory

Diagonal Bio AB (publ) (“Diagonal Bio” or “the Company”) announces a partnership with Gocksta Stud (Gocksta Stuteri), led by Anne-Sophie Thiam, to conduct a three-month pilot study, which begins immediately. This pilot test will evaluate LAMPlify’s potential for rapid detection of respiratory viruses in horses, with a specific focus on EHV1 (equine herpesvirus type 1). This virus poses a significant risk in horse breeding due to its potential to cause spontaneous abortion in pregnant mares.

Read more

Diagonal Bio AB Third Quarter Report (Q3 2024)

Regulatory

“One of the most exciting developments is our effort into a new application of our technology LAMPlify®—this time in the domain of swine diseases.”

Read more